Immunoregulatory Properties of Heme Oxygenase-1

Methods in Molecular Biology

Volumn 677, Issue , 2011, Pages 247-268

  Blancou, Philippe ^a,b   Tardif, Virginie ^b,c,d   Simon, Thomas ^b,c,d   Rémy, Séverine ^b,c,d   Carreño, Leandro ^e   Kalergis, Alexis ^e   Anegon, Ignacio ^b,c,d  

^a LUNAM UNIVERSITÉ   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c INSERM   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Allergy; Autoimmunity; Carbon monoxide; Dendritic cell; Heme oxygenase; Infection; Inflammation; Lymphocyte; Macrophage; Transplantation

Indexed keywords

ANTIINFLAMMATORY AGENT; BILIVERDIN; CARBON MONOXIDE; CYTOKINE; HEME; HEME OXYGENASE 1; SUPPRESSOR FACTOR;

ANIMAL; ARTICLE; AUTOIMMUNITY; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECT; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOPATHOLOGY; METABOLISM; MOUSE; OXIDATIVE STRESS; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNITY; BILIVERDINE; CARBON MONOXIDE; CELL CULTURE TECHNIQUES; CYTOKINES; HEME; HEME OXYGENASE-1; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM DISEASES; MICE; OXIDATIVE STRESS; RATS; SUPPRESSOR FACTORS, IMMUNOLOGIC;

EID: 79952197101     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-869-0_18     Document Type: Chapter

References (107)

1. Ryter S W, Alam J, and Choi A M (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583–650.
2. Poss KD and Tonegawa S (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94: 10919–10924.
3. Yet S F, Perrella M A, Layne M D, et al (1999) Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103: R23–R29.
4. Kapturczak M H, Wasserfall C, Brusko T, et al (2004) Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 165: 1045–1053.
5. George J F, Braun A, Brusko T M, et al (2008) Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am J Pathol 173: 154–160.
6. Chung S W, Liu X, Macias A A, et al (2008) Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest 118: 239–247.
7. Yachie A, Niida Y, Wada T, et al (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129–135.
8. Nath K A, Vercellotti G M, Grande J P, et al (2001) Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int 59: 106–117.
9. Pittock S T, Norby S M, Grande J P, et al (2005) MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: pathophysiologic correlates. Kidney Int 68: 611–622.
10. Otterbein L E, Bach F H, Alam J, et al (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422–428.
11. Lee T S and Chau L Y (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8: 240–246.
12. Rydkina E, Sahni A, Baggs R B, et al (2006) Infection of human endothelial cells with spotted fever group rickettsiae stimulates cyclooxygenase 2 expression and release of vasoactive prostaglandins. Infect Immun 74: 5067–5074.
13. Ren H, Leib S L, Ferriero D M, et al (2007) Induction of haem oxygenase-1 causes cortical non-haem iron increase in experimental pneumococcal meningitis: evidence that concomitant ferritin up-regulation prevents iron-induced oxidative damage. J Neurochem 100: 532–544.
14. Vareille M, Rannou F, Thelier N, et al (2008) Heme oxygenase-1 is a critical regulator of nitric oxide production in enterohemor-rhagic Escherichia coli-infected human enterocytes. J Immunol 180: 5720–5726.
15. Shiloh M U, Manzanillo P, and Cox J S (2008) Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 3: 323–330.
16. Kumar A, Deshane J S, Crossman D K, et al (2008) Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J Biol Chem 283: 18032–18039.
17. Zaki M H, Fujii S, Okamoto T, et al (2009) Cytoprotective function of heme oxygenase 1 induced by a nitrated cyclic nucleotide formed during murine salmonellosis. J Immunol 182: 3746–3756.
18. McAllister S C, Hansen S G, Ruhl R A, et al (2004) Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 103: 3465–3473.
19. Abdalla M Y, Ahmad I M, Spitz D R, et al (2005) Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol 76: 489–497.
20. Ghaziani T, Shan Y, Lambrecht R W, et al (2006) HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells. J Hepatol 45: 5–12.
21. Seixas E, Gozzelino R, Chora A, et al (2009) Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc Natl Acad Sci U S A 106: 15837–15842.
22. Tzima S, Victoratos P, Kranidioti K, et al (2009) Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production. J Exp Med 206: 1167–1179.
23. Protzer U, Seyfried S, Quasdorff M, Sass G, et al (2007) Antiviral activity and hepatopro-tection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 133: 1156–1165.
24. Epiphanio S, Mikolajczak S A, Goncalves L A, et al (2008) Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host Microbe 3: 331–338.
25. Sinnis P and Ernst J D (2008) CO-opting the host HO-1 pathway in tuberculosis and malaria. Cell Host Microbe 3: 277–279.
26. Pamplona A, Ferreira A, Balla J, et al (2007) Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13: 703–710.
27. Willis D, Moore A R, and Willoughby D A (2000) Heme oxygenase isoform expression in cellular and antibody-mediated models of acute inflammation in the rat. J Pathol 190: 627–634.
28. Kitada O, Kodama T, Kuribayashi K, et al (2001) Heme oxygenase-1 (HO-1) protein induction in a mouse model of asthma. Clin Exp Allergy 31: 1470–1477.
29. Xia Z W, Zhong W W, Xu L Q, et al (2006) Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J Immunol 177: 5936–5945.
30. Listopad J, Asadullah K, Sievers C, et al (2007) Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp Dermatol 16: 661–670.
31. Kirino M, Kirino Y, Takeno M, et al (2008) Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: implications for human disease. J Allergy Clin Immunol 122: 290–297, 297, e291–298.
32. Xia Z W, Xu L Q, Zhong W W, et al (2007) Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor-1. Am J Pathol 171: 1904–1914.
33. Takamiya R, Murakami M, Kajimura M, et al (2002) Stabilization of mast cells by heme oxygenase-1: an anti-inflammatory role. Am J Physiol Heart Circ Physiol 283: H861–H870.
34. Yasui Y, Nakamura M, Onda T, et al (2007) Heme oxygenase-1 inhibits cytokine production by activated mast cells. Biochem Biophys Res Commun 354: 485–490.
35. Chora A A, Fontoura P, Cunha A, et al (2007) Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 117: 438–447.
36. Hu C M, Lin H H, Chiang M T, et al (2007) Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice. Diabetes 56: 1240–1247.
37. Li M, Peterson S, Husney D, Inaba M, et al (2007) Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin. Antioxid Redox Signal 9: 855–863.
38. Goldberg A, Parolini M, Chin B Y, et al (2007) Toll-like receptor 4 suppression leads to islet allograft survival. FASEB J 21: 2840–2848.
39. Li Y, Li G, Dong W, Chen J, et al (2006) Transplantation of rat islets transduced with human heme oxygenase-1 gene using adeno-virus vector. Pancreas 33: 280–286.
40. Wagener F A, da Silva J L, Farley T, et al (1999) Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther 291: 416–423.
41. Wagener F A, Eggert A, Boerman O C, et al (2001) Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98: 1802–1811.
42. Chauveau C, Remy S, Royer P, et al (2005) Heme oxygenase-1 expression inhibits dendritic cell maturation and pro-inflammatory function but conserves IL-10 expression. Blood 106: 1694–1702.
43. Remy S, Blancou P, Tesson L, et al (2009) Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J Immunol 182: 1877–1884.
44. Soares M P, Lin Y, Anrather J, et al (1998) Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4: 1073–1077.
45. Sato K, Balla J, Otterbein L, Smith R, et al (2001) Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166: 4185–4194.
46. Yamashita K, Ollinger R, McDaid J, et al (2006) Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J 20: 776–778.
47. Nakao A, Kimizuka K, Stolz D B, et al (2003) Protective effect of carbon monoxide inhalation for cold-preserved small intestinal grafts. Surgery 134: 285–292.
48. Nakao A, Toyokawa H, Tsung A, et al (2006) Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant 6: 2243–2255.
49. Nakao A, Otterbein L E, Overhaus M, et al (2004) Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology 127: 595–606.
50. Neto J S, Nakao A, Kimizuka K, et al (2004) Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol 287: F979–F989.
51. Faleo G, Neto J S, Kohmoto J, et al (2008) Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 85: 1833–1840.
52. Kaizu T, Ikeda A, Nakao A, et al (2008) Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am J Physiol Gastrointest Liver Physiol 294: G236–G244.
53. Nakao A, Neto J S, Kanno S, et al (2005) Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 5: 282–291.
54. Bouche D, Chauveau C, Roussel J C, et al (2002) Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer. Transpl Immunol 9: 235–238.
55. Clarke H M, Shrivastava S, Motterlini R, et al (2009) Donor HO-1 expression inhibits inti-mal hyperplasia in unmanipulated graft recipients: a potential role for CD8+ T-cell modulation by carbon monoxide. Transplantation 88: 653–661.
56. Chauveau C, Bouchet D, Roussel J, et al (2002) Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2: 581–592.
57. Braudeau C, Bouchet D, Tesson L, et al (2004) Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 11: 701–710.
58. Araujo J A, Meng L, Tward A D, et al (2003) Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol 171: 1572–1580.
59. Kotsch K, Martins P N, Klemz R, et al (2007) Heme oxygenase-1 ameliorates ischemia/ reperfusion injury by targeting dendritic cell maturation and migration. Antioxid Redox Signal 9: 2049–2063.
60. Peche H, Trinite B, Martinet B, et al (2005) Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am J Transplant 5: 255–267.
61. Moreau A, Hill M, Thebault P, et al (2009) Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. FASEB J 23: 3070–3077.
62. Chabannes D, Hill M, Merieau E, et al (2007) A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110: 3691–3694.
63. Trigona W L, Porter C M, Horvath-Arcidiacono J A, et al (2007) Could heme-oxygenase-1 have a role in modulating the recipient immune response to embryonic stem cells? Antioxid Redox Signal 9: 751–756.
64. Becker T, Zu Vilsendorf A M, Terbish T, et al (2007) Induction of heme oxygenase-1 improves the survival of pancreas grafts by prevention of pancreatitis after transplantation. Transplantation 84: 1644–1655.
65. Wang H, Lee S S, Gao W, et al (2005) Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes 54: 1400–1406.
66. Wang H, Lee S S, Dell’Agnello C, et al (2006) Bilirubin can induce tolerance to islet allografts. Endocrinology 147: 762–768.
67. Lee S S, Gao W, Mazzola S, et al (2007) Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J 21: 3450–3457.
68. Lee D Y, Lee S, Nam J H, et al (2006) Minimization of immunosuppressive therapy after islet transplantation: combined action of heme oxygenase-1 and PEGylation to islet. Am J Transplant 6: 1820–1828.
69. Pulskens W P, Teske G J, Butter L M, et al (2008) Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS One 3: e3596.
70. Kaczorowski D J, Nakao A, Vallabhaneni R, et al (2009) Mechanisms of toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 87: 1455–1463.
71. Kaczorowski D J, Nakao A, Mollen K P, et al (2007) Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 84: 1279–1287.
72. Zhai Y, Shen X D, O’Connell R, et al (2004) Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173: 7115–7119.
73. Methe H, Zimmer E, Grimm C, et al (2004) Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 78: 1324–1331.
74. Tsuchihashi S, Zhai Y, Fondevila C, et al (2005) HO-1 upregulation suppresses type 1 IFN pathway in hepatic ischemia/reperfusion injury. Transplant Proc 37: 1677–1678.
75. Tsuchihashi S, Zhai Y, Bo Q, et al (2007) Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling. Transplantation 83: 1628–1634.
76. Nakahira K, Kim H P, Geng X H, et al (2006) Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 203: 2377–2389.
77. Arbour N C, Lorenz E, Schutte B C, et al (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187–191.
78. Rallabhandi P, Bell J, Boukhvalova M S, et al (2006) Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 177: 322–332.
79. Kruger B, Krick S, Dhillon N, et al (2009) Donor toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 106: 3390–3395.
80. Shen X D, Ke B, Zhai Y, et al (2005) Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 5: 1793–1800.
81. Exner M, Bohmig G A, Schillinger M, et al (2004) Donor heme oxygenase-1 genotype is associated with renal allograft function. Transplantation 77: 538–542.
82. Ozaki K S, Marques G M, Nogueira E, et al (2008) Improved renal function after kidney transplantation is associated with heme oxygenase-1 polymorphism. Clin Transplant 22: 609–616.
83. Baan C, Peeters A, Lemos F, et al (2004) Fundamental role for HO-1 in the self-protection of renal allografts. Am J Transplant 4: 811–818.
84. Courtney A E, McNamee P T, Middleton D, et al (2007) Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes. Am J Transplant 7: 908–913.
85. Hribova P, Reinke P, Petrasek J, et al (2008) Heme oxygenase-1 polymorphisms and renal transplantation outcomes: balancing at the detection limit of allelic association studies. Am J Transplant 8: 1077–1078; author reply 1079.
86. Ullrich R, Exner M, Schillinger M, et al (2005) Microsatellite polymorphism in the heme oxygenase-1 gene promoter and cardiac allograft vasculopathy. J Heart Lung Transplant 24: 1600–1605.
87. Buis C I, van der Steege G, Visser D S, et al (2008) Heme oxygenase-1 genotype of the donor is associated with graft survival after liver transplantation. Am J Transplant 8: 377–385.
88. Pae H O, Oh G S, Choi B M, et al (2003) Differential expressions of heme oxygenase-1 gene in CD25− and CD25+ subsets of human CD4+ T cells. Biochem Biophys Res Commun 306: 701–705.
89. Choi B M, Pae H O, Jeong Y R, et al (2005) Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 327: 1066–1071.
90. Biburger M, Theiner G, Schadle M, et al (2010) Pivotal advance: heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity. J Leukoc Biol 87: 193–202.
91. Blancou P and Anegon I (2010) Heme oxygenase-1 and dendritic cells: what else? J Leuckoc Biol 87: 185–187.
92. Zelenay S, Chora A, Soares M P, et al (2007) Heme oxygenase-1 is not required for mouse regulatory T cell development and function. Int Immunol 19: 11–18.
93. Liu Y, Li P, Lu J, Xiong W, et al (2008) Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. J Immunol 181: 1887–1897.
94. Yamashita K, McDaid J, Ollinger R, et al (2004) Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 18: 765–767.
95. Pae H O, Oh G S, Choi B M, et al (2004) Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhi- bition of IL-2 production. J Immunol 172: 4744–4751.
96. Song R, Mahidhara R S, Zhou Z, et al (2004) Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 172: 1220–1226.
97. Morse D, Pischke S E, Zhou Z, et al (2003) Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 278: 36993–36998.
98. Wang X M, Kim H P, Nakahira K, et al (2009) The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol 182: 3809–3818.
99. Poss KD and Tonegawa S (1997) Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 94: 10925–10930.
100. Clausen B E, Burkhardt C, Reith W, et al (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8: 265–277.
101. Mashreghi M F, Klemz R, Knosalla I S, et al (2008) Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3. J Immunol 180: 7919–7930.
102. Hill M, Pereira V, Chauveau C, et al (2005) Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxyge-nase. FASEB J 19: 1957–1968.
103. Andersen M H, Sorensen R B, Brimnes M K, et al (2009) Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients. J Clin Invest 119: 2245–2256.
104. De Wilde V, Van Rompaey N, Hill M, et al (2009) Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 9: 2034–2047.
105. Li M, Peterson S, Husney D, et al (2007) Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle 6: 567–571.
106. Kohmoto J, Nakao A, Sugimoto R, et al (2008) Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury. J Thorac Cardiovasc Surg 136: 1067–1075.
107. Taille C, El-Benna J, Lanone S, et al (2005) Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 280: 25350–25360.